MANILA, Philippines — Ayala Healthcare Holdings Inc. (AC Health), through its technology arm Vigos, has made an investment in Fibronostics, a global US-based healthcare technology company focusing on non-invasive algorithm-based solutions for diagnostic testing. This move enables AC Health to beef up its digital portfolio, said Paolo Borromeo, AC Health president and chief executive officer. “This investment fits well into our Vigos health technology portfolio, which we are proud to say is the first digital health portfolio in the Philippines. With the investment, AC Health will launch two Fibronostics products, LiverFAST and HealthFACTR in its FamilyDOC clinics. HealthFACTR, on the other hand, is as a 10-minute metabolic health check-up solution that provides immediate risk assessment and personalized recommendations, based on the latest medical guidelines, AC Health said.

Source: Philippine Star June 11, 2019 17:48 UTC